588 related articles for article (PubMed ID: 16990566)
41. Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells.
Klemm DJ; Majka SM; Crossno JT; Psilas JC; Reusch JE; Garat CV
J Cardiovasc Pharmacol; 2011 Aug; 58(2):181-91. PubMed ID: 21562428
[TBL] [Abstract][Full Text] [Related]
42. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms.
Riches K; Franklin L; Maqbool A; Peckham M; Adams M; Bond J; Warburton P; Feric NT; Koschinsky ML; O'Regan DJ; Ball SG; Turner NA; Porter KE
Int J Biochem Cell Biol; 2013 Aug; 45(8):1776-83. PubMed ID: 23726972
[TBL] [Abstract][Full Text] [Related]
44. Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity.
Lu J; Landerholm TE; Wei JS; Dong XR; Wu SP; Liu X; Nagata K; Inagaki M; Majesky MW
Dev Biol; 2001 Dec; 240(2):404-18. PubMed ID: 11784072
[TBL] [Abstract][Full Text] [Related]
45. RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cip1 expression.
Zuckerbraun BS; Shapiro RA; Billiar TR; Tzeng E
Circulation; 2003 Aug; 108(7):876-81. PubMed ID: 12874183
[TBL] [Abstract][Full Text] [Related]
46. The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation.
Bear MD; Li M; Liu Y; Giel-Moloney MA; Fanburg BL; Toksoz D
J Biol Chem; 2010 Oct; 285(43):32919-32926. PubMed ID: 20696764
[TBL] [Abstract][Full Text] [Related]
47. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation.
Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Sato M; Doi H; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1384-90. PubMed ID: 15217807
[TBL] [Abstract][Full Text] [Related]
48. Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA.
Palomino-Morales R; Perales S; Torres C; Linares A; Alejandre MJ
Curr Vasc Pharmacol; 2016; 14(4):345-52. PubMed ID: 26924327
[TBL] [Abstract][Full Text] [Related]
49. Role of Rho kinase signalling in healthy and varicose human saphenous veins.
Cario-Toumaniantz C; Evellin S; Maury S; Baron O; Pacaud P; Loirand G
Br J Pharmacol; 2002 Sep; 137(2):205-12. PubMed ID: 12208777
[TBL] [Abstract][Full Text] [Related]
50. Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries.
Matrougui K; Tankó LB; Loufrani L; Gorny D; Levy BI; Tedgui A; Henrion D
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1288-93. PubMed ID: 11498455
[TBL] [Abstract][Full Text] [Related]
51. Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats.
Lin G; Craig GP; Zhang L; Yuen VG; Allard M; McNeill JH; MacLeod KM
Cardiovasc Res; 2007 Jul; 75(1):51-8. PubMed ID: 17428455
[TBL] [Abstract][Full Text] [Related]
52. Rho plays a central role in regulating local cell-matrix mechanical interactions in 3D culture.
Lakshman N; Kim A; Bayless KJ; Davis GE; Petroll WM
Cell Motil Cytoskeleton; 2007 Jun; 64(6):434-45. PubMed ID: 17342762
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of cGMP phosphodiesterase 5 suppresses serotonin signalling in pulmonary artery smooth muscles cells.
Li M; Sun X; Li Z; Liu Y
Pharmacol Res; 2009 May; 59(5):312-8. PubMed ID: 19416631
[TBL] [Abstract][Full Text] [Related]
54. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
[TBL] [Abstract][Full Text] [Related]
55. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
56. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
57. Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase.
Fernstrom K; Farmer P; Ali MS
J Cell Physiol; 2005 Dec; 205(3):402-13. PubMed ID: 16021628
[TBL] [Abstract][Full Text] [Related]
58. Extracellular matrix effect on RhoA signaling modulation in vascular smooth muscle cells.
Lim SM; Kreipe BA; Trzeciakowski J; Dangott L; Trache A
Exp Cell Res; 2010 Oct; 316(17):2833-48. PubMed ID: 20599954
[TBL] [Abstract][Full Text] [Related]
59. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
[TBL] [Abstract][Full Text] [Related]
60. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
